REPEVAX (diphtheria tetanus pertussis (acellular) and poliomyelitis (inactivated)): Reviews and patient testimonials
Medication indications
REPEVAX
REPEVAX is indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in persons from 3 years of age as a booster following primary immunization.
The use of REPEVAX should be determined on the basis of official recommendations.
Molecule: diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)
Patients' opinions on REPEVAX
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.